AKEBIA THERAPEUTICS, INC. (AKBA) Gross margin 2018–2025
AKEBIA THERAPEUTICS, INC. (AKBA) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.3%FY2025 · since FY2018: 96.3% → 83.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.3% | +22.7 pp |
| FY2024 | 60.6% | -1.3 pp |
| FY2023 | 61.9% | -8.8 pp |
| FY2022 | 70.7% | +41.9 pp |
| FY2021 | 28.8% | +29.4 pp |
| FY2020 | -0.6% | -57.2 pp |
| FY2019 | 56.6% | -39.6 pp |
| FY2018 | 96.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice